Increasing Prevalence of Chronic Diseases to Foster the Growth of the Global Pain Management Devices Market

The global pain management devices market is anticipated to grow at a considerable CAGR of 7.3% during the forecast period (2021-2027). The market growth is mainly driven by the increasing prevalence of chronic diseases along with the availability of technically advanced pain management devices in the market. The increasing prevalence of chronic diseases is one of the key factors creating demand for the market. Cancer, neurovascular diseases, cardiovascular diseases among others are several chronic diseases that lower the immunity power of individuals and lead to chronic pain. The increasing prevalence of chronic diseases is one of the key factors creating demand for the market. 

Browse the full report description Global Pain Management Devices Market by Application (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Facial and Migraine Pain, Other (Trauma)), by Device Type (Neurostimulators Devices, Analgesic Infusion Pumps, Ablation Devices) - Industry Size, Global Trends, Competitive Analysis and Forecast, 2021-2027 at https://www.omrglobal.com/industry-reports/pain-management-devices-market

The National health council, the US, highlighted that around half of all adults have a chronic condition, along with approximately 8%of children were been reported by their parents to have limited activities that are aging from 5 to 17. A high prevalence of chronic pain leads to the increased dependency of one person on other. Therefore, pain management is a must to perform the daily routine without the support of others. These devices support providing relief along with good health. The dependency of one person on the other can be reduced with the help of a wearable pain management device. So, with various offering among patients of chronic diseases, the demand for pain management devices are increasing.

Recent Development

• In September 2020, Boston Scientific had announced the European launch of the Wave Writer Alpha. This is regarded as a portfolio of SCS systems that are spinal cord stimulator systems. This portfolio consists of 4 MRI conditional, implantable pulse generators (IPGs) that are Bluetooth enabled along with expanded personalization that is based on needs such as rechargeable and non-rechargeable options and waveforms access that will cover pain-related multiple areas.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Application

o By Device Type

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Abbott, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Medtronic, Nevro Corp.
• Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pain Management Devices Market Report Segment

By Application

• Cancer Pain
• Neuropathic Pain
• Musculoskeletal Pain
• Facial and Migraine Pain 
• Other (Trauma)

By Types 

• Neurostimulators Devices
• Analgesic Infusion Pumps
• Ablation Devices

Global Pain Management Devices Market Report Segment by Region